HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 07-12-2007, 09:44 AM   #1
Grace
Guest
 
Posts: n/a
BRCA 1 & 2: Lani's post moved up!

Lani,

I think some interested women may miss your post on the other thread, so I'm putting it here as well:

<table id="post127544" class="tborder" align="center" border="0" cellpadding="6" cellspacing="0" width="100%"><tbody><tr valign="top"><td class="alt1" id="td_post_127544" style="border-right: 1px solid rgb(170, 135, 153);">Genes May Not Affect Odds
Of Surviving Breast Cancer
By JOSEPH PEREIRA
July 12, 2007; Page B6
Breast-cancer patients carrying two well-known genes linked to the disease have the same survival chances as noncarriers of the genes who develop the disease, according to a study by Israeli and Canadian researchers.

The study was aimed in part at shedding light on whether breast-cancer treatment should be tailored differently for women with the two gene mutations, known as BRCA1 and BRCA2. The results provided no decisive answers on that question, but could provide some comfort to carriers who might feel the odds stacked against them.

The study of 1,545 breast-cancer patients found 10-year survival rates of 49% for women carrying BRCA1, 48% for carriers of BRCA2 and 51% for noncarriers, including deaths from other causes. The slight differences weren't statistically significant. The study was published in this week's New England Journal of Medicine.

The differences in death rates from breast cancer among the three groups also weren't statistically significant. After 10 years with the disease, about 33% of both noncarriers and carriers of the BRCA1 gene had died from it.

"As a result of the study, we can offer to the medical community the assurance that there is no difference in the prognosis between carriers and noncarriers," said Gad Rennert, the study's lead author and chairman of the medical faculty at Israel's Technion university in Haifa.

The finding is somewhat of a surprise, as carriers of the mutant genes tend to develop a more virulent form of the disease that strikes before age 50, and can be resistant to certain types of treatments. Previous studies have produced conflicting results, partly because they were conducted on a smaller scale. But researchers say that this study -- conducted by scientists at Technion and the University of Toronto -- is by far the largest of its kind, giving more weight to its conclusion.

One problem that has stymied researchers is a scarcity of patients with the condition. Less than 1% of the general female population carry the BRCA genetic mutations. But among Jewish women of Ashkenazi, or European, descent, the two mutations are especially prevalent. For the study, researchers culled their breast-cancer subjects from the Israel National Cancer Registry, gathering medical records and tumor-tissue samples from patients dating back to the late 1980s.

It remains to be seen whether the study's results will influence the treatment of patients with the mutation. Simply learning that a patient has the genes "may add little to the clinician's ability to select a therapy or predict the course of the disease," writes Patricia Hartge, a National Cancer Institute researcher who wrote an accompanying editorial. She added, however, that the finding gives women who know they have the mutation and their doctors another factor to consider as they ponder such precautionary measures as prophylactic surgery before the onset of the disease.

Dr. Hartge said one perplexing statistic in the study involves a small number of patients who died within 10 years even though their tumors were small and hadn't spread to the lymph nodes. While the overall conclusion of the study is "generally comforting," she said, "there is this little disturbing footnote that is calling for further research on the subject."
<!-- / message --> </td> </tr> <tr> <td class="alt2" style="border-style: none solid solid; border-color: -moz-use-text-color rgb(170, 135, 153) rgb(170, 135, 153); border-width: 0px 1px 1px;"> </td> <td class="alt1" style="border-style: none solid solid none; border-color: -moz-use-text-color rgb(170, 135, 153) rgb(170, 135, 153) -moz-use-text-color; border-width: 0px 1px 1px 0px;" align="right"> <!-- controls --> </td></tr></tbody></table>
  Reply With Quote
Old 07-12-2007, 01:50 PM   #2
Believe51
Senior Member
 
Believe51's Avatar
 
Join Date: Jun 2007
Location: RHODE ISLAND (Ed getting me a latte on 2nd Cancerversary Cruise 2008) 'BELIEVE': To accept as true or real, To have faith in, To presume ALWAYS BELIEVE
Posts: 3,000
Wink Thanks Grace

Thanks for pulling this forward, I do not know how I missed it!!

Waiting For A Miracle>>Believe51
__________________
9/7/06Husband 50yrs=StageIV IBC/HER2+,BoneMets10/06TaxotereX10,'H'1X wk,Zometa,Tamoxifen4/12/07Last Tax5/18/07Pet=Rapid Cell Activity,No Organ Mets,Lytic Lesions,Degeneration,Some Bone Repair5/07ChemoFail6/01/07Pleural Thoracentisis=Effusions,NoMalignantCells6/19/07+7/2/07DFCI
6/25/07BrainMRI=BrainMets,Many<9mm7/10/07WBR/PelvisRad37.5Gx15&Nutritionist8/19/07T/X9/20/07BrainMRI=2<2mm10/6/07Pet=BoneProgression
10/24/07ChemoFail11/9/07A/Cx10,EndTam12/7/07Faslodex12/10/07Muga7512/13/07BlasticLesions1/7/08BrainMRI=Clear4/1/08Pet=BoneImprovement,
NoProgression,Stable4/7/08BrainPerfect5/16/08Last A/C8/26/08BrainMets=10(<9mm)9/10/08Gamma10/30/08Met=5mm12/19/08Gamma5mets5
12/22/08SpinalMets1/14/09SpinalRads2/17/09BrainMRI=NoNewMets4/20/09BoneScan5/14/09Ixempra6/1/09BrainMRI=NumerousMets6/24/09DFCIw/DrBurstein6/26/09Continue
Ixempra/Faslodex/Zometa~TM now lower7/17/09Stop Ixempra By Choice9/21/09HOSPICE10/16/09Earned His Deserved Wings And Halo=37 Month Fight w/Stage 4 IBC, Her2+++,My Hero!!
Believe51 is offline   Reply With Quote
Old 07-13-2007, 12:25 AM   #3
harrie
Senior Member
 
harrie's Avatar
 
Join Date: Mar 2007
Location: Hilo, Hawaii
Posts: 1,867
Thank you for posting the article. Interesting and something that has been lurking in the back of my mind for quite some time. I found out I was BRCA2 positive one yr ago. I had a bilat mastectomy in 11/06 and I wonder, with no breasts, what are the chances of the BRCA2 gene exhibiting itself in another part of my body.
Maryanne
__________________
*** MARYANNE *** aka HARRIECANARIE

1993: right side DCIS, lumpectomy, rads
1999: left side DCIS, lumpectomy, rads, tamoxifen

2006:
BRCA 2 positive
Stage I, invasive DCIS (6mm x 5mm)
Grade: intermediate
sentinal node biopsy: neg
HER2/neu amplified 4.7
ER+/PR+
TOPO II neg
Oncotype dx 20
Bilat mastectomy with DIEP flap reconstruction
oophorectomy

2007:
6 cycles TCH (taxotere, carboplatin, herceptin)
finished 1 yr herceptin 05/07
Arimidex, stopped after almost 1 yr
Femara
harrie is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:25 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter